For psoriasis, targeting skin protein may help control inflammation

When tested in mice, psoriasis became more severe when more interferon kappa was present.

12:55 PM

Author | Noah Fromson

woman holding her wrist
Getty Images

Results from a Michigan Medicine study reveal that targeting a protein found in the skin may reduce the severity of psoriasis.  

Interferons play a major role in activating the body's response to viral threats, but they have also been detected in the lesions of many psoriasis patients at abnormal levels. Psoriasis is an autoimmune disease that causes overproduction of skin cells and impacts nearly 30 million people in the world.

Using a model that mimics psoriasis in mice, researchers found that changing the levels of interferon kappa, a protein made by skin cells, altered the severity of inflammation and production of cell signaling molecules, called cytokines, that induce inflammation characteristic of psoriasis. Investigators found more psoriasis-like inflammation when more interferon kappa was present, while decreasing interferon kappa levels reduced disease.

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts.

The findings, published in the Journal of Investigative Dermatology, suggest using therapies to modulate interferon states may limit inflammation in psoriasis patients.

"We've known that psoriatic inflammation is marked by interferon-related gene expression, but how interferons alter the severity of the disease has not been clear," said J. Michelle Kahlenberg, M.D., Ph.D., associate professor of rheumatology at Michigan Medicine and senior author of the paper. "Understanding how interferon kappa may modulate psoriasis brings us one step closer to optimizing our treatments."

Understanding how interferon kappa may modulate psoriasis brings us one step closer to optimizing our treatments.
J. Michelle Kahlenberg, M.D., Ph.D.

The research team induced psoriasis in mouse models, splitting them into groups with interferon kappa at low, normal or elevated levels. The overexpressed protein alone didn't induce the disease, but it primed the skin for the inflammatory response that followed.  

"This work shows how the context of the skin environment can shape inflammatory responses." said Mehrnaz Gharaee-Kermani, DVM, M.P.H., Ph.D., lead author of the study and a senior research lab specialist at Michigan Medicine. "It will be exciting to see how this can be applied in clinic."

SEE ALSO: Genetic Prediction Model Helps Identify Arthritis Risk in Psoriasis Patients

The research team is conducting further studies to understand the role of interferon kappa in psoriasis patients through their Taubman Institute-sponsored study at Michigan Medicine and in partnership with Johann E. Gudhonsson, M.D., Ph.D., receiving funding through the National Psoriasis Foundation. Several treatments are used against the disease, but there is no cure.

A few current psoriasis drugs inhibit interferons, but many that are more specific are still in the trial phase. Coupled with the study's findings, personalized medicine will be paramount as physicians attempt to treat this disease, Kahlenberg said.

"Until now, treatments have been tested by studying a drug in hundreds of patients, lumping the average of them all together and targeting the average of those patients," Kahlenberg said. "As any patient who has been on these medications will tell you, this trial–and-error approach wastes patient time and money trying to get control of the disease. Understanding a patient's background level of interferon might help us target things within that person to make their disease better faster and stay in remission."

MORE FROM THE LAB: Subscribe to our weekly newsletter

Paper cited: "Interferon Kappa is a Rheostat for Development of Psoriasiform Inflammation," Journal of Investigative Dermatology. DOI: 0.1016/j.jid.2021.05.029


More Articles About: Lab Report Psoriasis All Research Topics Skin Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories veteran sitting with hands closed with person writing notes across from them
Health Lab
Insights into factors contributing to suicide risk among veterans
Recent studies by Michigan Medicine IHPI experts offer new insights into factors contributing to suicide risk among veterans and opportunities to strengthen suicide prevention programs
yellow dices with different emotional faces on each side
Health Lab
Could personality tests help make bipolar disorder treatment more precise? 
Bipolar disorder treatment could become more precisely focused if guided by the results of personality tests that reveal personality styles, or combinations of personality traits.
doctors in surgery room over surgery table with cooler open with labels on it
Health Lab
Why donor hearts fail in cold storage — and how to prevent it
Researchers have discovered a new molecular process that occurs when donor hearts are preserved in cold storage which contributes to failure after transplant, a study in both humans and animals shows. Fortunately, therapy that is typically prescribed for high blood pressure can target this process to reduce cold preservation associated with cardiac injury. This discovery has potential to improve the consistent function of donor hearts and extend the distance they can be safely transported in cold storage.
mom and child with pacificer and older teen with pacifier in his mouth on other side of blue bench
Health Lab
Are parents waiting too long to stop pacifier use or thumb-sucking in kids?
A national poll looks at how parents tackle thumb-sucking and pacifier use —two habits that can benefit children but that can also be challenging to stop.
person looking at ipad with provider on screen smiling
Health Lab
Telemedicine had an impact on carbon emissions equivalent to reducing up to 130,000 car trips each month in 2023
Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of up to 130,000 gas operated vehicles, suggesting it could have a positive effect on climate change, UCLA and Michigan led research finds.
girl hugging teddy bear with alcohol bottles on ground
Health Lab
1 in 4 kids live with parents who have alcohol or other drug problems
Children living with parents who have addiction issues, also called substance used disorder, have higher risks later in life. A new study shows 1 in 4 currently live in such households.